Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination
暂无分享,去创建一个
John P. Moore | D. Montefiori | R. Sanders | C. Labranche | P. Klasse | S. D. de Taeye | J. Burger | Edith E. Schermer | K. Sliepen | A. Torrents de la Peña | Alba Torrents de la Peña | Kwinten Sliepen
[1] T. Kepler,et al. Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations , 2017, Nature Communications.
[2] Ben Murrell,et al. HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage , 2017, Immunity.
[3] E. Go,et al. Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization , 2017, Cell reports.
[4] John P. Moore,et al. Native‐like Env trimers as a platform for HIV‐1 vaccine design , 2017, Immunological reviews.
[5] Mehran Kardar,et al. Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens , 2016, Proceedings of the National Academy of Sciences.
[6] I. Sola,et al. Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses , 2016, PLoS pathogens.
[7] John P. Moore,et al. Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C , 2016, PLoS pathogens.
[8] Bryan Briney,et al. Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies. , 2016, Cell reports.
[9] Young Do Kwon,et al. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G , 2016, Cell.
[10] Ben Murrell,et al. Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort , 2016, PLoS pathogens.
[11] John P. Moore,et al. Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes , 2015, Cell.
[12] John P. Moore,et al. Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens , 2015, Proceedings of the National Academy of Sciences.
[13] Lynn Morris,et al. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies , 2015, Nature Medicine.
[14] A. Lapedes,et al. Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants , 2015, Viruses.
[15] G. Debnath,et al. D-101 HIV-1 neutralizing antibodies induced by native-like envelope trimers , 2016 .
[16] Daniel W. Kulp,et al. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site , 2015, PLoS pathogens.
[17] Mehran Kardar,et al. Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies , 2015, Cell.
[18] John P. Moore,et al. A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene , 2015, Journal of Virology.
[19] A. Kissenpfennig,et al. Elucidation of the RamA Regulon in Klebsiella pneumoniae Reveals a Role in LPS Regulation , 2015, PLoS pathogens.
[20] B. Korber,et al. A Multivalent Clade C HIV-1 Env Trimer Cocktail Elicits a Higher Magnitude of Neutralizing Antibodies than Any Individual Component , 2014, Journal of Virology.
[21] J. Reifman,et al. Simulation of B Cell Affinity Maturation Explains Enhanced Antibody Cross-Reactivity Induced by the Polyvalent Malaria Vaccine AMA1 , 2014, The Journal of Immunology.
[22] Raphael Gottardo,et al. Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2013, Journal of Virology.
[23] John P. Moore,et al. A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies , 2013, PLoS pathogens.
[24] Lynn Morris,et al. Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape , 2012, Nature Medicine.
[25] N. Haigwood,et al. Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies , 2011, Journal of Virology.
[26] J. Arthos,et al. Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. , 2010, Vaccine.
[27] J. Mascola,et al. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. , 2006, Virology.
[28] J. Mascola,et al. Multiclade Human Immunodeficiency Virus Type 1 Envelope Immunogens Elicit Broad Cellular and Humoral Immunity in Rhesus Monkeys , 2005, Journal of Virology.